Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hänsel W[au]:

Excess carrier-envelope phase noise generation in saturable absorbers. Raabe N et al. Opt Lett. (2017)

After 65 years, research is still fun. Hansel W et al. Annu Rev Anim Biosci. (2013)

From hyperkeratosis to apoptosis: lessons learned from 65 years of research. Hansel W et al. Biol Reprod. (2012)

Search results

Items: 1 to 50 of 255

1.

Excess carrier-envelope phase noise generation in saturable absorbers.

Raabe N, Feng T, Mero M, Tian H, Song Y, Hänsel W, Holzwarth R, Sell A, Zach A, Steinmeyer G.

Opt Lett. 2017 Mar 15;42(6):1068-1071. doi: 10.1364/OL.42.001068.

PMID:
28295094
2.

Dynamics of ultra-broadband terahertz quantum cascade lasers for comb operation.

Li H, Laffaille P, Gacemi D, Apfel M, Sirtori C, Leonardon J, Santarelli G, Rösch M, Scalari G, Beck M, Faist J, Hänsel W, Holzwarth R, Barbieri S.

Opt Express. 2015 Dec 28;23(26):33270-94. doi: 10.1364/OE.23.033270.

PMID:
26831993
3.

Fiber chirped pulse amplifier at 2.08 μm emitting 383-fs pulses at 10 nJ and 7 MHz.

Hoogland H, Wittek S, Hänsel W, Stark S, Holzwarth R.

Opt Lett. 2014 Dec 1;39(23):6735-8. doi: 10.1364/OL.39.006735.

PMID:
25490665
4.

After 65 years, research is still fun.

Hansel W.

Annu Rev Anim Biosci. 2013 Jan;1:1-20. doi: 10.1146/annurev-animal-031412-103722. Epub 2012 Dec 13.

PMID:
25387010
5.

From hyperkeratosis to apoptosis: lessons learned from 65 years of research.

Hansel W.

Biol Reprod. 2012 Jul 19;87(1):19, 1-11. doi: 10.1095/biolreprod.112.100305. Print 2012 Jul. Review. No abstract available.

PMID:
22517625
6.

14-Qubit entanglement: creation and coherence.

Monz T, Schindler P, Barreiro JT, Chwalla M, Nigg D, Coish WA, Harlander M, Hänsel W, Hennrich M, Blatt R.

Phys Rev Lett. 2011 Apr 1;106(13):130506. Epub 2011 Mar 31.

PMID:
21517367
7.

[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.

Aggarwal S, Ndinguri MW, Solipuram R, Wakamatsu N, Hammer RP, Ingram D, Hansel W.

Int J Cancer. 2011 Oct 1;129(7):1611-23. doi: 10.1002/ijc.26132. Epub 2011 Jul 20.

8.

Trapped-ion antennae for the transmission of quantum information.

Harlander M, Lechner R, Brownnutt M, Blatt R, Hänsel W.

Nature. 2011 Mar 10;471(7337):200-3. doi: 10.1038/nature09800. Epub 2011 Feb 23.

PMID:
21346764
10.

The essentiality of the epididymal fat pad for spermatogenesis.

Hansel W.

Endocrinology. 2010 Dec;151(12):5565-7. doi: 10.1210/en.2010-1146. No abstract available.

PMID:
21098126
11.

Realization of universal ion-trap quantum computation with decoherence-free qubits.

Monz T, Kim K, Villar AS, Schindler P, Chwalla M, Riebe M, Roos CF, Häffner H, Hänsel W, Hennrich M, Blatt R.

Phys Rev Lett. 2009 Nov 13;103(20):200503. Epub 2009 Nov 13.

PMID:
20365970
12.

Realization of the quantum Toffoli gate with trapped ions.

Monz T, Kim K, Hänsel W, Riebe M, Villar AS, Schindler P, Chwalla M, Hennrich M, Blatt R.

Phys Rev Lett. 2009 Jan 30;102(4):040501. Epub 2009 Jan 28.

PMID:
19257408
13.

Absolute frequency measurement of the 40Ca+ 4s(2)S_(1/2)-3d(2)D_(5/2) clock transition.

Chwalla M, Benhelm J, Kim K, Kirchmair G, Monz T, Riebe M, Schindler P, Villar AS, Hänsel W, Roos CF, Blatt R, Abgrall M, Santarelli G, Rovera GD, Laurent P.

Phys Rev Lett. 2009 Jan 16;102(2):023002. Epub 2009 Jan 13.

PMID:
19257267
14.

4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3.

Bodendiek SB, Mahieux C, Hänsel W, Wulff H.

Eur J Med Chem. 2009 May;44(5):1838-52. doi: 10.1016/j.ejmech.2008.10.033. Epub 2008 Nov 5.

15.

Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.

Jia L, Noker PE, Piazza GA, Leuschner C, Hansel W, Gorman GS, Coward LU, Tomaszewski J.

J Pharm Pharmacol. 2008 Nov;60(11):1441-8. doi: 10.1211/jpp.60.11.0004.

16.

Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB/C mice.

Bogacki M, Enright FM, Todd WJ, Hansel W.

Reprod Biol. 2008 Jul;8(2):135-47.

PMID:
18677401
17.

Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities.

Deters M, Knochenwefel H, Lindhorst D, Koal T, Meyer HH, Hänsel W, Resch K, Kaever V.

Pharm Res. 2008 Aug;25(8):1822-7. doi: 10.1007/s11095-008-9579-2. Epub 2008 Apr 22.

PMID:
18427962
18.

Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.

Hansel W, Leuschner C, Enright F.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):26-33. Epub 2007 Feb 15. Review.

PMID:
17382461
19.

Process tomography of ion trap quantum gates.

Riebe M, Kim K, Schindler P, Monz T, Schmidt PO, Körber TK, Hänsel W, Häffner H, Roos CF, Blatt R.

Phys Rev Lett. 2006 Dec 1;97(22):220407. Epub 2006 Dec 1.

PMID:
17155786
20.

Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.

Hansel W, Enright F, Leuschner C.

Mol Cell Endocrinol. 2007 Jan 2;260-262:183-9. Epub 2006 Nov 13.

PMID:
17101210
21.

LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.

Leuschner C, Kumar CS, Hansel W, Soboyejo W, Zhou J, Hormes J.

Breast Cancer Res Treat. 2006 Sep;99(2):163-76. Epub 2006 Jun 3.

PMID:
16752077
22.

Scalable multiparticle entanglement of trapped ions.

Häffner H, Hänsel W, Roos CF, Benhelm J, Chek-al-Kar D, Chwalla M, Körber T, Rapol UD, Riebe M, Schmidt PO, Becher C, Gühne O, Dür W, Blatt R.

Nature. 2005 Dec 1;438(7068):643-6.

PMID:
16319886
23.

The human Ca2+-activated K+ channel, IK, can be blocked by the tricyclic antihistamine promethazine.

Wittekindt OH, Schmitz A, Lehmann-Horn F, Hänsel W, Grissmer S.

Neuropharmacology. 2006 Mar;50(4):458-67. Epub 2005 Nov 28.

PMID:
16310228
24.

Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.

Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hänsel W, Wulff H.

Mol Pharmacol. 2005 Nov;68(5):1254-70. Epub 2005 Aug 11.

PMID:
16099841
25.

Targeting breast and prostate cancers through their hormone receptors.

Leuschner C, Hansel W.

Biol Reprod. 2005 Nov;73(5):860-5. Epub 2005 Jul 20. Review.

PMID:
16033998
26.
27.

[Photosensitization due to drugs: adverse reaction and beneficial effect].

Bode CW, Zager A, Hänsel W.

Med Monatsschr Pharm. 2005 Mar;28(3):85-94; quiz 95-6. German.

PMID:
15794367
28.

Photodynamic and photo-cross-linking potential of bergamottin.

Bode CW, Zager A, Hänsel W.

Pharmazie. 2005 Jan;60(1):78-9.

PMID:
15700786
29.

Membrane disrupting lytic peptides for cancer treatments.

Leuschner C, Hansel W.

Curr Pharm Des. 2004;10(19):2299-310. Review.

PMID:
15279610
30.

Bell states of atoms with ultralong lifetimes and their tomographic state analysis.

Roos CF, Lancaster GP, Riebe M, Häffner H, Hänsel W, Gulde S, Becher C, Eschner J, Schmidt-Kaler F, Blatt R.

Phys Rev Lett. 2004 Jun 4;92(22):220402. Epub 2004 Jun 3.

PMID:
15245202
31.

Deterministic quantum teleportation with atoms.

Riebe M, Häffner H, Roos CF, Hänsel W, Benhelm J, Lancaster GP, Körber TW, Becher C, Schmidt-Kaler F, James DF, Blatt R.

Nature. 2004 Jun 17;429(6993):734-7.

PMID:
15201903
32.

Control and measurement of three-qubit entangled states.

Roos CF, Riebe M, Häffner H, Hänsel W, Benhelm J, Lancaster GP, Becher C, Schmidt-Kaler F, Blatt R.

Science. 2004 Jun 4;304(5676):1478-80.

33.

Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.

Vennekamp J, Wulff H, Beeton C, Calabresi PA, Grissmer S, Hänsel W, Chandy KG.

Mol Pharmacol. 2004 Jun;65(6):1364-74.

PMID:
15155830
34.

3-Alkyl- and 3-aryl-7H-furo[3,2-g]chromen-7-ones as blockers of the voltage-gated potassium channel Kv1.3.

Wernekenschnieder A, Körner P, Hänsel W.

Pharmazie. 2004 Apr;59(4):319-20.

PMID:
15125582
35.

Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.

Baell JB, Gable RW, Harvey AJ, Toovey N, Herzog T, Hänsel W, Wulff H.

J Med Chem. 2004 Apr 22;47(9):2326-36.

PMID:
15084131
36.

Evidence that lamprey GnRH-III does not release FSH selectively in cattle.

Amstalden M, Zieba DA, Garcia MR, Stanko RL, Welsh TH Jr, Hansel WH, Williams GL.

Reproduction. 2004 Jan;127(1):35-43.

PMID:
15056768
37.

Growth repression in diethylstilbestrol/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate.

Zaleska M, Waclawik A, Bodek G, Zezula-Szpyra A, Li X, Janowski T, Hansel WH, Rahman NA, Ziecik AJ.

Exp Biol Med (Maywood). 2004 Apr;229(4):335-44.

PMID:
15044717
39.

Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.

Hansel W, Leuschner C, Gawrońska B, Enright F.

Reprod Biol. 2001 Jul;1(1):20-32.

PMID:
14666172
40.

The potential for improving the growth and development of cultured farm animal oocytes.

Hansel W.

Anim Reprod Sci. 2003 Dec 15;79(3-4):191-201. Review.

PMID:
14643105
41.

Nitric oxide as a local mediator of prostaglandin F2alpha-induced regression in bovine corpus luteum: an in vivo study.

Jaroszewski JJ, Skarzynski DJ, Hansel W.

Exp Biol Med (Maywood). 2003 Oct;228(9):1057-62.

PMID:
14530515
42.

Magnetic microchip traps and single-atom detection.

Long R, Steinmetz T, Hommelhoff P, Hänsel W, Hänsch TW, Reichel J.

Philos Trans A Math Phys Eng Sci. 2003 Jul 15;361(1808):1375-89.

PMID:
12869314
43.

Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.

Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W.

Prostate. 2003 Sep 1;56(4):239-49.

PMID:
12858351
44.

Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.

Zaleska M, Bodek G, Jana B, Hansel W, Ziecik AJ.

Exp Clin Endocrinol Diabetes. 2003 May;111(3):146-53.

PMID:
12784188
45.

A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.

Bodek G, Rahman NA, Zaleska M, Soliymani R, Lankinen H, Hansel W, Huhtaniemi I, Ziecik AJ.

Breast Cancer Res Treat. 2003 May;79(1):1-10.

PMID:
12779076
46.

Influence of nitric oxide on the secretory function of the bovine corpus luteum: dependence on cell composition and cell-to-cell communication.

Jaroszewski JJ, Skarzynski DJ, Blair RM, Hansel W.

Exp Biol Med (Maywood). 2003 Jun;228(6):741-8.

PMID:
12773707
47.

Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.

Leuschner C, Enright FM, Gawronska B, Hansel W.

Breast Cancer Res Treat. 2003 Mar;78(1):17-27.

PMID:
12611453
48.

Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2-induced luteolysis in cattle.

Skarzynski DJ, Jaroszewski JJ, Bah MM, Deptula KM, Barszczewska B, Gawronska B, Hansel W.

Biol Reprod. 2003 May;68(5):1674-81. Epub 2002 Nov 27.

PMID:
12606417
49.

Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.

Gawronska B, Leuschner C, Enright FM, Hansel W.

Gynecol Oncol. 2002 Apr;85(1):45-52.

PMID:
11925119
50.

Bose-Einstein condensation on a microelectronic chip.

Hänsel W, Hommelhoff P, Hänsch TW, Reichel J.

Nature. 2001 Oct 4;413(6855):498-501.

PMID:
11586353

Supplemental Content

Loading ...
Support Center